Overview
An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier
Status:
Completed
Completed
Trial end date:
2010-05-01
2010-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Abbott
AbbVieTreatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Criteria
Inclusion Criteria- BMI between 20-35 kg/m^2 inclusive.
Exclusion Criteria
- Males: history, current or suspected prostate or breast cancer.
- Females: pregnant or lactating.